Correspondence 0001193125-24-029298 from BIOLASE, INC (BIOL) (CIK 0000811240)
BIOLASE, INC (BIOL) (CIK 0000811240)
Date: Feb. 9, 2024 · CIK: 0000811240 · Accession: 0001193125-24-029298
AI Filing Summary & Sentiment
File numbers found in text: 333-276596
Letter
BIOLASE, Inc.
27042 Towne Centre Drive, Suite 270
Lake Forest, California 92610
(949) 361-1200
February 9, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jessica Ansart
Re: BIOLASE, Inc.
Registration Statement on Form S-1, as amended
File No: 333-276596
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
BIOLASE, Inc. (the “Registrant”) hereby requests that the United States Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1, as amended (File No. 333-276596), to become effective on Monday, February 12, 2024, at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable.
The Registrant understands that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes its counsel, Leslie Marlow, Esq. or Patrick J. Egan, Esq. of Blank Rome LLP, to orally modify or withdraw this request for acceleration. Please contact Ms. Marlow at (212) 885-5358 or Mr. Egan at (212) 885-5346 with any questions you may have concerning this request, and please notify either Ms. Marlow or Mr. Egan when this request for acceleration has been granted.
Very truly yours,
BIOLASE, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP BIOLASE, Inc. 27042 Towne Centre Drive, Suite 270 Lake Forest, California 92610 (949) 361-1200 February 9, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Jessica Ansart Re: BIOLASE, Inc. Registration Statement on Form S-1, as amended File No: 333-276596 Request for Acceleration of Effectiveness Ladies and Gentlemen: BIOLASE, Inc. (the “Registrant”) hereby requests that the United States Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1, as amended (File No. 333-276596), to become effective on Monday, February 12, 2024, at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable. The Registrant understands that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement. The Registrant hereby authorizes its counsel, Leslie Marlow, Esq. or Patrick J. Egan, Esq. of Blank Rome LLP, to orally modify or withdraw this request for acceleration. Please contact Ms. Marlow at (212) 885-5358 or Mr. Egan at (212) 885-5346 with any questions you may have concerning this request, and please notify either Ms. Marlow or Mr. Egan when this request for acceleration has been granted. Very truly yours, BIOLASE, INC. By: /s/ John R. Beaver Name: John R. Beaver Title: Chief Executive Officer cc: Leslie Marlow, Esq., Blank Rome LLP Patrick J. Egan, Esq., Blank Rome LLP